129 related articles for article (PubMed ID: 29849291)
1. Sodium-glucose Cotransporter-2 Induced Diabetic Ketoacidosis with Minimal Hyperglycemia.
Gammons DT; Counselman FL
Clin Pract Cases Emerg Med; 2018 Feb; 2(1):47-50. PubMed ID: 29849291
[TBL] [Abstract][Full Text] [Related]
2. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
Diaz-Ramos A; Eilbert W; Marquez D
Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
[TBL] [Abstract][Full Text] [Related]
3. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
[TBL] [Abstract][Full Text] [Related]
4. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
[TBL] [Abstract][Full Text] [Related]
5. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
Altowayan WM
Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
[TBL] [Abstract][Full Text] [Related]
6. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
Allison R; Goldstein D; Musso MW
J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990
[TBL] [Abstract][Full Text] [Related]
8. Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin.
Tiwari K; Sharma NR; Pokhrel M; Basnet A; Kaplan M
Cureus; 2023 Nov; 15(11):e49402. PubMed ID: 38149142
[TBL] [Abstract][Full Text] [Related]
9. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
[TBL] [Abstract][Full Text] [Related]
10. Canagliflozin-associated diabetic ketoacidosis: a case report.
Chai PR; Bonney C; Blohm E; Boyer EW; Babu KM
Toxicol Commun; 2017; 1(1):2-5. PubMed ID: 29978156
[TBL] [Abstract][Full Text] [Related]
11. Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Calçada MB; Fernandes L; Soares Costa R; Montezinho S; Martins Duarte F; Frutuoso L; Freitas AR
Clin Pract; 2021 Apr; 11(2):216-218. PubMed ID: 33917274
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis.
Ray GM; Rodriguez C; Schulman SM; Sarangarm P; Bardack M; Bouchonville MF
Clin Pract Cases Emerg Med; 2019 May; 3(2):140-143. PubMed ID: 31061971
[TBL] [Abstract][Full Text] [Related]
13. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
Andrews TJ; Cox RD; Parker C; Kolb J
J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
[TBL] [Abstract][Full Text] [Related]
14. [Sodium-glucose-cotransporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis].
Fisker F; Møller N; Lauritzen ES
Ugeskr Laeger; 2019 May; 181(21):. PubMed ID: 31124439
[TBL] [Abstract][Full Text] [Related]
15. Euglycemic Diabetic Ketoacidosis: A Review.
Modi A; Agrawal A; Morgan F
Curr Diabetes Rev; 2017; 13(3):315-321. PubMed ID: 27097605
[TBL] [Abstract][Full Text] [Related]
16. Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Fukuda M; Nabeta M; Muta T; Fukami K; Takasu O
Int J Emerg Med; 2020 Jan; 13(1):2. PubMed ID: 31969112
[TBL] [Abstract][Full Text] [Related]
17. Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin.
Kelmenson DA; Burr K; Azhar Y; Reynolds P; Baker CA; Rasouli N
J Investig Med High Impact Case Rep; 2017; 5(2):2324709617712736. PubMed ID: 28634592
[TBL] [Abstract][Full Text] [Related]
18. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Goldenberg RM; Berard LD; Cheng AYY; Gilbert JD; Verma S; Woo VC; Yale JF
Clin Ther; 2016 Dec; 38(12):2654-2664.e1. PubMed ID: 28003053
[TBL] [Abstract][Full Text] [Related]
19. Cardiac arrest from acute myocardial infarction complicated with sodium-glucose cotransporter 2 inhibitor-associated ketoacidosis.
Dai Z; Nishihata Y; Kawamatsu N; Komatsu I; Mizuno A; Shimizu M; Toya N; Ishimatsu S; Komiyama N
J Cardiol Cases; 2017 Feb; 15(2):56-60. PubMed ID: 30546697
[TBL] [Abstract][Full Text] [Related]
20. Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin.
Rashid O; Farooq S; Kiran Z; Islam N
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27177938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
